Home » Stocks » Teligent

Teligent, Inc. (TLGT)

Stock Price: $2.26 USD -0.08 (-3.42%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 12.17M
Revenue (ttm) 60.22M
Net Income (ttm) -43.24M
Shares Out 5.39M
EPS (ttm) -8.06
PE Ratio n/a
Forward PE 6.29
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $2.26
Previous Close $2.34
Change ($) -0.08
Change (%) -3.42%
Day's Open 2.34
Day's Range 2.22 - 2.36
Day's Volume 29,815
52-Week Range 1.90 - 10.90

More Stats

Market Cap 12.17M
Enterprise Value 191.74M
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date n/a
Shares Outstanding 5.39M
Float 3.96M
EPS (basic) -8.1
EPS (diluted) -8.06
FCF / Share -4.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 678,072
Short Ratio 7.46
Short % of Float 16.45%
Beta 1.82
PE Ratio n/a
Forward PE 6.29
P/FCF Ratio n/a
PS Ratio 0.20
PB Ratio 5.05
Revenue 60.22M
Operating Income -23.33M
Net Income -43.24M
Free Cash Flow -22.27M
Net Cash -179.56M
Net Cash / Share -33.33
Gross Margin 21.20%
Operating Margin -38.75%
Profit Margin -71.80%
FCF Margin -36.98%
ROA -4.94%
ROE -192.52%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$20.00*
Low
20.0
Current: $2.26
High
20.0
Target: 20.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue65.9065.8760.2063.0144.2533.7418.228.567.816.09
Revenue Growth0.05%9.41%-4.46%42.4%31.15%85.14%112.82%9.7%28.09%-
Gross Profit23.5222.3927.3734.6921.3216.796.152.782.261.11
Operating Income-8.02-15.10-11.802.54-3.193.91-0.08-3.14-2.97-3.63
Net Income-25.12-36.26-15.19-11.996.675.25-0.08-3.93-3.01-3.42
Shares Outstanding5.385.365.335.315.294.984.353.983.942.38
Earnings Per Share-4.70-6.80-2.80-2.30-0.700.90-0.30-1.00-0.80-2.00
Operating Cash Flow-18.42-13.280.40-0.45-15.51-3.89-0.62-2.37-2.39-3.01
Capital Expenditures-8.20-25.29-40.43-16.66-6.00-0.83-0.29-0.34-0.35-0.16
Free Cash Flow-26.62-38.57-40.03-17.10-21.51-4.73-0.91-2.72-2.74-3.17
Cash & Equivalents15.7112.6026.6966.0187.191592.102.542.975.12
Total Debt1871541211111031043.021.020.570.10
Net Cash / Debt-171-141-94.29-45.39-15.8455.28-0.911.522.405.02
Assets20719118518318119715.439.439.6411.35
Liabilities2121721401271141588.243.001.871.00
Book Value-5.3118.4244.7556.6766.7639.137.196.437.7710.35
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Teligent, Inc.
Country United States
Employees 252
CEO Timothy B. Sawyer

Stock Information

Ticker Symbol TLGT
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TLGT

Description

Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.